CDKN2A and lymphoma: This result is consistent with increased expression of p16 in Δ3C virus-infected lymphomas (Fig 2C), given that p16 inhibits E2F1 expression by preventing phosphorylation/inactivation of pRb by the cyclin D/CDK4/6 complex [29,33].